Standard

Triglyceride levels in LDL

SLC2A2 · rs10513689

Where this position leads

What the study found

Who was studied 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.0391 higher (95% confidence interval 0.028-0.051); p = 3 × 10⁻¹¹.

How common The A allele had a frequency of about 13% in the people studied.

Where it sits Chromosome 3, band 3q26.2 — in an intron of SLC2A2.

What each result means

A/A Two copies of the version the research linked to Triglyceride levels in LDL. That is the strongest link of the three results. A link in a study is not a diagnosis.

A/G One copy of the version the research linked to Triglyceride levels in LDL. That is a smaller link than two copies.

G/G No copy of the version the research linked to Triglyceride levels in LDL. This is the starting point the study compared everyone against.

Source

Genome-wide characterization of circulating metabolic biomarkers

Karjalainen MK, Karthikeyan S, Oliver-Williams C, Sliz E, Allara E, Fung WT, Surendran P, Zhang W, Jousilahti P, Kristiansson K, Salomaa V, Goodwin M

and 75 more — show all

Hughes DA, Boehnke M, Fernandes Silva L, Yin X, Mahajan A, Neville MJ, van Zuydam NR, de Mutsert R, Li-Gao R, Mook-Kanamori DO, Demirkan A, Liu J, Noordam R, Trompet S, Chen Z, Kartsonaki C, Li L, Lin K, Hagenbeek FA, Hottenga JJ, Pool R, Ikram MA, van Meurs J, Haller T, Milaneschi Y, Kähönen M, Mishra PP, Joshi PK, Macdonald-Dunlop E, Mangino M, Zierer J, Acar IE, Hoyng CB, Lechanteur YTE, Franke L, Kurilshikov A, Zhernakova A, Beekman M, van den Akker EB, Kolcic I, Polasek O, Rudan I, Gieger C, Waldenberger M, Asselbergs FW, Hayward C, Fu J, den Hollander AI, Menni C, Spector TD, Wilson JF, Lehtimäki T, Raitakari OT, Penninx BWJH, Esko T, Walters RG, Jukema JW, Sattar N, Ghanbari M, Willems van Dijk K, Karpe F, McCarthy MI, Laakso M, Järvelin MR, Timpson NJ, Perola M, Kooner JS, Chambers JC, van Duijn C, Slagboom PE, Boomsma DI, Danesh J, Ala-Korpela M, Butterworth AS, Kettunen J

China Kadoorie Biobank Collaborative Group · Estonian Biobank Research Team · FinnGen

Nature · 2024 · PMID 38448586 · open access

Questions about rs10513689

What is rs10513689?

rs10513689 is a single position in the genome, in or near the SLC2A2 gene. Published research associates it with triglyceride levels in ldl. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does rs10513689 affect how medicines work?

SLC2A2 carries pharmacogenomic findings for Metformin. That is educational information, not a prescription or a dosing guide. Any decision to start, stop or change a medicine belongs with the clinician or pharmacist managing your treatment.

Does having rs10513689 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs10513689 come from?

GWAS Catalog, Nature 2024, PMID:38448586. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Triglyceride levels in LDL (rs10513689). MyGeneLog™. https://www.mygenelog.com/variants/rs10513689

← See all variants